Probenecid: A New Hope for Easing Opioid Withdrawal Symptoms

Probenecid: A New Hope for Easing Opioid Withdrawal Symptoms In the ongoing battle against the opioid crisis, researchers at the University of Calgary have uncovered a promising new avenue for helping patients taper off opioid medications. The drug probenecid, traditionally used to treat gout, is now being tested for its potential to alleviate the severe […]

Gout Treatment Advances: Shanton Pharma’s SAP-001 and Its Potential Impact

Gout Treatment Advances: Shanton Pharma’s SAP-001 and Its Potential Impact Shanton Pharma has recently announced the full enrollment of its Phase IIb clinical trial for SAP-001, a promising new treatment for refractory and tophaceous gout. This milestone marks a significant step forward in the development of therapies aimed at addressing the unmet medical needs of […]